Early research (Phase 1)Study completedNCT06973005
What this trial is testing
Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants
Who this might be right for
Advanced Chronic Liver DiseaseHealthy Participants
AstraZeneca 16